ENG/中
老虎證券
市场
行情
24/7新闻
产品
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
基因編輯
337.87
+4.19
1.25%
漲家數:
2
跌家數:
2
平家數:
- -
市盈率:
- -
高:
349.63
開:
332.15
低:
327.72
收:
333.69
成交量:
2,507.97萬
成交額:
3.70億
市值:
76.02億
流通市值:
71.73億
資料載入中...
總覽
新聞資訊
動物實驗顯示:CRISPR療法實現一次輸注三年控脂
格隆汇
·
11/17
Seawolf Therapeutics完成A輪融資,Versant Ventures、MPM BioImpact、諾華創投基金、禮來、CRISPR Therapeutics等參投
美股速递
·
11/16
Beam Therapeutics:Beacon試驗所有次要終點均達成,包括VOC相關住院豁免
美股速递
·
11/10
Beam Therapeutics:Beacon試驗顯示risto-cel在鐮狀細胞病中達到主要療效與安全性終點
美股速递
·
11/10
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/BK4556/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4556","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4556\",,,,,undefined,":{"symbol":"BK4556","market":"US","secType":"PLATE","nameCN":"基因編輯","latestPrice":337.87247,"timestamp":1795208399999,"preClose":333.68512,"halted":0,"volume":25079733,"delay":0,"changeRate":0.012549,"floatShares":0,"shares":0,"eps":0,"marketStatus":"休市中","change":4.187347,"latestTime":"11-20 16:00:00 EST","open":332.1485,"high":349.62683,"low":327.71887,"amount":369598266.01022,"amplitude":0.065655,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1795424400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":2.262786,"peRate":-7.022121,"turnoverRate":0.057081,"increases":2,"decrements":2,"flats":0,"marketCap":7601908608,"floatMarketCap":7172667904},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4556\",,,,,undefined,":{"symbol":"BK4556","high":349.62683,"amplitude":0.065655,"preClose":333.68512,"low":327.71887,"pbRate":"2.262786","latestPrice":337.87247,"volume":25079733,"delay":0,"open":332.1485,"prevYearClose":431.70972,"prevWeekClose":360.4512,"prevMonthClose":440.4987,"prevQuarterClose":441.4069,"fiveDayClose":360.4512,"twentyDayClose":407.6888,"sixtyDayClose":497.3026,"secType":"PLATE","market":"US","turnoverRate":0.057081,"peRate":-7.022121,"marketCap":7601908608,"floatMarketCap":7172667904,"timestamp":1795208399999,"nameCN":"基因編輯"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4556\",,,,undefined,":{"bkCode":"BK4556","up":2,"down":2,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4556\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2684262376","title":"動物實驗顯示:CRISPR療法實現一次輸注三年控脂","url":"https://stock-news.laohu8.com/highlight/detail?id=2684262376","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2684262376?lang=zh_tw&edition=fundamental","pubTime":"2026-11-17 07:07","pubTimestamp":1794870439,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4585","SYNB","BK4139","BK4611","LU1861559042.SGD","ARKG","BK4556","CRSP","LU1861558580.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187133930","title":"Seawolf Therapeutics完成A輪融資,Versant Ventures、MPM BioImpact、諾華創投基金、禮來、CRISPR Therapeutics等參投","url":"https://stock-news.laohu8.com/highlight/detail?id=1187133930","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187133930?lang=zh_tw&edition=fundamental","pubTime":"2026-11-16 18:01","pubTimestamp":1794823276,"startTime":"0","endTime":"0","summary":"Seawolf Therapeutics成功完成A轮融资,本轮融资由Versant Ventures、MPM BioImpact、诺华创投基金、礼来以及CRISPR Therapeutics AG等多家机构共同参与。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0122379950.USD","SG9999014914.USD","LU0094547139.USD","LU0158827948.USD","SG9999014880.SGD","LU1093756168.USD","LU0061475181.USD","LU2237443549.SGD","LU2023250504.SGD","LU0820561909.HKD","LU0689472784.USD","LU1127390331.HKD","LU1366192091.USD","SG9999015978.USD","LU0323591593.USD","LU1983299246.USD","LU2602419157.SGD","SGXZ31699556.SGD","LU0345770993.USD","ELIL","LU2264538146.SGD","LU1548497426.USD","LU1861559042.SGD","IE00BJJMRX11.SGD","LU0964807845.USD","LU2211817866.USD","BK4581","LU0683600562.USD","LU2168564222.USD","LU1035775433.USD","LU1551013425.SGD","LU1712237335.SGD","LU1989771016.USD","LU1064131342.USD","LU0174119429.USD","LU2746668974.SGD","IXJ","LU2211815571.USD","LU0466842654.USD","LU1691799644.USD","SG9999014906.USD","SGXZ51526630.SGD","LU2462157665.USD","LU0471298777.SGD","IE00BJLML261.HKD","LU0417517546.SGD","IE0004445015.USD","LU0353189763.USD","LU2023251221.USD","LU2236285917.USD","LU0289739699.SGD","GB00BDT5M118.USD","LU0432979614.USD","IE00BJJMRY28.SGD","LU1623119135.USD","FTXH","LU1323610961.USD","LU2361045086.USD","LU0203202063.USD","LU1814569148.SGD","LU0106261372.USD","LU2106854487.HKD","LU2237443978.SGD","LU2491050071.SGD","SGXZ81514606.USD","IE0001KFT4U8.USD","BK4588","LU2271345857.HKD","THNR","LU2471134879.HKD","LU1145028129.USD","LU0943347566.SGD","PPH","LU0738911758.USD","LU2468319806.SGD","LU0385154629.USD","PJP","LU0553294199.USD","IE00BFSS7M15.SGD","LU1804176565.USD","SG9999014898.SGD","IHE","LU0006306889.USD","CURE","LU0661504455.SGD","LU0823434740.USD","LU0823416689.USD","IE00BWXC8680.SGD","LU2471134523.USD","LU2746668461.USD","WDNA","LU1232071149.USD","LU0133085943.USD","LU0320765992.SGD","LU2168564495.EUR","LU2471134952.CNY","BK4585","BK4534","LU1093756325.SGD","CRSP","LU0210536198.USD","LLYX","LU0354030438.USD","LU1629891620.HKD","OZEM","IE0004445239.USD","LU2491049909.HKD","LU0353189680.USD","BK4533","IE00BJJMRZ35.SGD","GDOC","LU0225283273.USD","LU0109394709.USD","IE0005OL40V9.USD","LU1069344957.HKD","MEDX","LU2896262040.SGD","LU1023059063.AUD","LU0882574139.USD","LU2360032135.SGD","SG9999015986.USD","LU1868836591.USD","LU2125154935.USD","LU1280957306.USD","XLV","MEDI","IE00BFTCPJ56.SGD","LU1720051017.SGD","IE0002141913.USD","LU0097036916.USD","LU1861558580.USD","LU2750360997.AUD","SG9999001176.SGD","SG9999013999.USD","SGXZ99366536.SGD","LU2552382132.HKD","LU2237443382.USD","LU2237443895.HKD","TRUH","LU0096364046.USD","LU1061106388.HKD","ILDR","LU2111349929.HKD","LU2089284900.SGD","LU1551013342.USD","LU2265009873.SGD","SG9999018865.SGD","LU0787776722.HKD","LU2028103732.USD","LU0158827781.USD","LU0234572021.USD","LU0820562030.AUD","LU2756315318.SGD","IE00BFSS8Q28.SGD","LU1291159041.SGD","LU2168564065.EUR","IE00B2B36J28.USD","LU2087625088.SGD","LU2213496289.HKD","LU0320765059.SGD","IE00B4R5TH58.HKD","LU2361044949.HKD","LU2089984988.USD","LU0708995401.HKD","LU0058720904.USD","LU2750360641.GBP","CANC","LU1974910355.USD","LU0823434583.USD","IE00B1BXHZ80.USD","BK4556","IYH","BK4007","IE00BN29S564.USD","LU2112291526.USD","FHLC","BK4139","SG9999018857.SGD","RXL","LU0354030511.USD","LU0114720955.EUR","LU2168563687.JPY","LU2237443622.USD","LU2063271972.USD","LU0882574055.USD","LU0672654240.SGD","LU2462591350.SGD","SG9999017495.SGD","LU0545039389.USD","LU2108987350.USD","LU2360106947.USD","LU2237443465.HKD","LU1267930730.SGD","LU0471298694.HKD","ARKG","IE0009355771.USD","SG9999015945.SGD","TMED","LU0203201768.USD","LU2552382215.SGD","LU0256863811.USD","LU2417539215.USD","LU0949170772.SGD","LU0786609619.USD","IE00BJT1NW94.SGD","LU2357305700.SGD","BK4516","LU0820561818.USD","LU0316494557.USD","LU0256863902.USD","LU0266013472.USD","LU1057294990.SGD","LU1868837300.USD","LU1979441026.SGD","LU1003077747.HKD","JDOC","LLY","LU0640476718.USD","LU1988902786.USD","LU2456880835.USD","LU2461242641.AUD","MHIP","IE00B1XK9C88.USD","LU2361044865.SGD","VHT","IE00B4JS1V06.HKD","LU0238689110.USD","SGXZ57979304.SGD","LU1720051108.HKD","LU2023250330.USD","LU0079474960.USD","LU1868836914.USD","LU2125154778.USD","BK4599","IE00BKPKM429.USD","LU0011850046.USD","LU2324357040.USD","LU1153585028.USD","LU1868836757.USD","IE00BK4W5M84.HKD","AGNG","ELIS","HRTS","LU1868837136.USD","LU0456855351.SGD","IE00B775H168.HKD","LU1917777945.USD","LU2471134796.USD","LLYZ","LU2756315664.SGD","LLII","IE00B7KXQ091.USD","LU0109391861.USD","IE00BKDWB100.SGD","LU2168564149.EUR","LU2491050154.USD","BK4611","LU2237438978.USD","LU2089283258.USD","SG9999015952.SGD","IE00BK4W5L77.USD","LU0345770308.USD","SG9999001176.USD","LU0198837287.USD","LU2552382058.USD","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170714716","title":"Beam Therapeutics:Beacon試驗所有次要終點均達成,包括VOC相關住院豁免","url":"https://stock-news.laohu8.com/highlight/detail?id=1170714716","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170714716?lang=zh_tw&edition=fundamental","pubTime":"2026-11-10 20:02","pubTimestamp":1794312128,"startTime":"0","endTime":"0","summary":"Beam Therapeutics公司宣布,Beacon试验成功触及全部次要终点,其中涵盖血管闭塞危象(VOC)患者的免于住院这一指标。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4611","BK4535","BK4505","BK4588","BK4585","LU1861558580.USD","LU1861559042.SGD","BEAM","BK4139","BK4556"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197134313","title":"Beam Therapeutics:Beacon試驗顯示risto-cel在鐮狀細胞病中達到主要療效與安全性終點","url":"https://stock-news.laohu8.com/highlight/detail?id=1197134313","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197134313?lang=zh_tw&edition=fundamental","pubTime":"2026-11-10 20:01","pubTimestamp":1794312076,"startTime":"0","endTime":"0","summary":"Beam Therapeutics公司宣布,其Beacon临床试验中,risto-cel用于治疗镰状细胞病已成功达成主要疗效终点和安全性终点。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861559042.SGD","BK4505","BK4535","BK4139","BK4588","LU1861558580.USD","BK4611","BK4556","BEAM","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":4,"code":"91000000","status":"200"}]}}